about
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacementRadioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropinPotential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer.Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012Tandem mass spectrometry as a novel tool for elucidating pituitary-thyroid relationships.Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancerAge and the thyrotropin response to hypothyroxinemia.Agreement of immunoassay and tandem mass spectrometry in the analysis of cortisol and free t4: interpretation and implications for clinicians3,3'-Diiodothyronine concentrations in hospitalized or thyroidectomized patients: results from a pilot study.Total and free thyroxine and triiodothyronine: measurement discrepancies, particularly in inpatientsChanges in steroid concentrations with the timing of corticotropin stimulation testing in participants with adrenal sufficiencyAge modifies the response to recombinant human thyrotropin.Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction.Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.Levothyroxine replacement doses are affected by gender and weight, but not age.Weight changes in euthyroid patients undergoing thyroidectomySalivary Function after Radioiodine Therapy: Poor Correlation between Symptoms and Salivary Scintigraphy.Use of steroid profiles in determining the cause of adrenal insufficiencyCushing's syndrome during pregnancy: personal experience and review of the literature.Ectopic intratracheal thyroid: an illustrative case report and literature review.Atypical presentation of a patient with both kallmann syndrome and a craniopharyngioma: case report and literature review.Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis.Update on the treatment of hypothyroidismThyroid medications during pregnancy.Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populationsThe measurement of free thyroxine by isotope dilution tandem mass spectrometry.Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy.Role of radioactive iodine for adjuvant therapy and treatment of metastases.Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive ParametersA pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancerTiming of levothyroxine administration affects serum thyrotropin concentration.The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism.Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters.A pilot study: subclinical hypothyroidism and free thyroid hormone measurement by immunoassay and mass spectrometry.Management of recurrent cervical papillary thyroid cancer.Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level.Risks and safety of combination therapy for hypothyroidism.Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer.The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values.
P50
Q28649731-2109B230-C7CB-4F54-82AA-A488A994CC3FQ33399549-98A2B0F8-587A-440E-860F-CD5101B18E7BQ33404577-20DBDBC3-EA1C-47DB-9D77-426737A4CFADQ33570297-BEE8023C-2296-472A-B298-8C0EED6A9B9AQ33801438-ED8D946A-FB18-49E9-87BB-479434EE40D1Q33889219-2659D353-EA39-45DC-AA0C-A6F60EDF5AEFQ34031984-65F3C486-AAD8-49F3-BF28-E21EA496BCFFQ34034194-D3DC5543-50C1-4335-8631-934B3DDC43BDQ34289592-309B6085-C78E-4E55-A43D-E149C87E7CC4Q34295944-B527BC6A-C1B5-4B50-9DED-6BF7025D85C9Q34338648-49C842EE-E15E-4D89-B08A-95306AE78DCEQ34342816-8D9EFA53-A174-493A-9E4B-DE9358DDA85DQ34712784-64CC2DB0-7BDA-436D-B290-C48E21EE308DQ34752050-5D1370E3-DAB5-4B63-BC4A-729BA8278D72Q35140854-B6C02B8A-8B9B-4431-A2ED-461E737A01F5Q35590118-24673DCC-D032-40DD-9F26-DAD738D8DA41Q35750722-22D389BF-77C1-4146-8B63-601DA5955F0DQ35950444-A35A0FA8-7704-4F93-9124-94AE46F7DA28Q36037971-D91D34F1-DEAF-4547-8347-458D7A053A3FQ36147252-CF9A992F-7183-4CF1-BA50-0C5649B81E5AQ36201937-D8389A1F-B60F-441F-985F-414FD1C37279Q36365361-CC11DFD5-2FD6-4B57-8022-EA19A6DF9E07Q36425038-D9C75048-61D2-4DC4-87C8-85FF9B0204D8Q36508610-FEAC7C65-ECAA-4EEB-87B1-093FD34C5E34Q36787933-FF47034E-9317-4F6A-A0A2-DD7BDE8DC1CCQ36797145-0F3000FA-7307-4A03-8D69-80BCB2DD51E7Q36811043-47A4D4E9-082C-4D9D-8070-7F3764422E59Q36876592-D96F004E-40D7-488A-91D3-3193D46D750BQ37020034-E48A723A-6E26-48F2-9E72-DDE6D0CA755CQ37163510-2F862745-DE03-45E9-A66E-C8FE4DCEDDA4Q37379546-CF6F5102-F3B7-4E8F-B352-00E9F1E6967BQ37407679-F39394EA-A1CE-4809-9FCB-4ED8820AB505Q37460181-BAB5AF5F-B3E1-4243-83CC-EFA186E08284Q37515808-26982C41-15B6-4CA2-98AB-CE2993D80B41Q37677404-5E4E9A44-943B-4E1F-AA61-C682ECE451D0Q38217172-2743D30E-223E-4B80-B16B-98418DC70820Q38668982-28871C7A-DE52-4496-90EE-7D680E41D707Q38823533-E12DC6D9-23DD-42B3-BEC3-3639242681CBQ39834839-00321BDE-84A2-4967-810F-2EE847FDDA69Q40131634-10D6343D-2DA8-4CF9-9B1C-5AB5A709BC7D
P50
name
Jacqueline Jonklaas
@en
Jacqueline Jonklaas
@nl
type
label
Jacqueline Jonklaas
@en
Jacqueline Jonklaas
@nl
prefLabel
Jacqueline Jonklaas
@en
Jacqueline Jonklaas
@nl